Old Web
English
Sign In
Acemap
>
authorDetail
>
L. Van Moorter
L. Van Moorter
Oncology
Internal medicine
Medicine
Carboplatin
Stage III Non-Small Cell Lung Cancer
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
PO-0750 MATURE RESULTS OF A PHASE 2 DOSE-ESCALATION STUDY IN UNRESECTABLE, LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER
2012
Radiotherapy and Oncology
C. Collen
D. Schallier
M. Meysman
L. Van Moorter
Samuel Bral
Hendrik Everaert
D Verdries
M. De Ridder
Show All
Source
Cite
Save
Citations (0)
Multicenter phase II trial of carboplatin (Cb) and gemcitabine (G) followed by concurrent chemoradiation in patients with unresectable stage III non-small-cell lung cancer (NSCLC): FEV1 as prognostic marker
2008
Journal of Clinical Oncology
Paul Germonpre
Annelies Janssens
L. Van Moorter
Dirk Verresen
Danny Galdermans
Roger Devogelaere
Hugo Ottevaere
Yves Mentens
C. De Pooter
Chris Goor
Show All
Source
Cite
Save
Citations (0)
1